Skip to main content
logo
Kringle Pharma, Inc. (TYO:4884)
Japan flag Japan · Delayed Price · Currency is JPY
445.00
-11.00 (-2.41%)
Aug 27, 2026, 3:30 PM JST

Kringle Pharma Ratios and Metrics

Millions JPY. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Market Capitalization
3,7303,1595,7604,3182,4213,919
Market Cap Growth
14.15%-45.16%33.41%78.32%-38.21%-
Enterprise Value
2,6631,5273,3041,937-271,690
Last Close Price
445.00462.00847.00798.00450.00907.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
PS Ratio
10.9043.8772.0062.586.1913.56
PB Ratio
2.982.422.732.140.871.56
P/TBV Ratio
2.982.422.732.140.871.56
P/OCF Ratio
----161.42-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
EV/Sales Ratio
7.7821.2141.3028.07-5.85

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Debt / Equity Ratio
-0.85-1.24-1.10-1.06-0.99-0.85
Asset Turnover
0.170.030.030.020.130.12
Inventory Turnover
0.33---0.270.39
Quick Ratio
9.7415.4018.5210.6117.4317.47
Current Ratio
17.1718.8521.5212.5219.8020.74
Return on Equity (ROE)
-61.23%-53.65%-36.63%-35.52%-12.50%-12.83%
Return on Assets (ROA)
-24.51%-23.50%-19.00%-19.07%-9.11%-8.98%
Return on Capital Employed (ROCE)
-42.80%-46.10%-31.10%-36.90%-14.00%-14.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Earnings Yield
-21.67%-29.00%-13.13%-19.78%-13.67%-7.68%
Buyback Yield / Dilution
-7.53%-6.92%-18.72%-11.00%-16.91%-7422.44%